Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

A DirEct to PatieNt Study in Chronic Pain

NCT: NCT05515341 · COMPLETED

NCT IDNCT05515341
StatusCOMPLETED
Start Date2023-01-10
Completion2026-05-11

Brief Summary

To compile real-world, direct from patient clinical outcomes and objective metrics in patients who have received or plan to receive a commercially approved interventional medical device therapy/procedure for chronic pain in routine clinical practice.

Frequently Asked Questions

What is A DirEct to PatieNt Study in Chronic Pain?

A DirEct to PatieNt Study in Chronic Pain is a clinical trial registered under NCT05515341. Current status: COMPLETED.

What is the status of NCT05515341?

The current status of NCT05515341 (A DirEct to PatieNt Study in Chronic Pain) is: COMPLETED.

When did A DirEct to PatieNt Study in Chronic Pain start?

A DirEct to PatieNt Study in Chronic Pain started on 2023-01-10.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.